“Revolutionizing CKD Treatment: The Promising Future of ProKidney Stock in 2025”
Rilparencel: A Potential Breakthrough in Treating Chronic Kidney Disease A New Hope for CKD Patients Rilparencel is ProKidney’s main candidate for treating Chronic Kidney Disease (CKD). This innovative therapy is designed to stabilize kidneys, offering new hope for patients suffering from this debilitating condition. CKD is a progressive disease that affects millions of people worldwide,…